Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (201-210 of 293) with videos related to

Pageof 30
Sort By:
Journal of Hepatology|November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTRMayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.
The American Journal of Gastroenterology|June 7, 2019
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Vincent Wai-Sun Wong, Elisabetta Bugianesi, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
The American Journal of Gastroenterology|April 14, 2025
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter StudyGian Paolo Caviglia, Arianna Ferro, Roberta D'Ambrosio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver DiseaseSalvatore Petta, Giada Sebastiani, Mauro Viganò, et al.
Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
Pageof 30

Showing results (201-210 of 293) with videos related to

Sort By:
Pageof 30
Journal of Hepatology|November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTRMayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.
The American Journal of Gastroenterology|June 7, 2019
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Vincent Wai-Sun Wong, Elisabetta Bugianesi, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
Hepatology (Baltimore, Md.)|October 5, 2023
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteriaGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
The American Journal of Gastroenterology|April 14, 2025
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter StudyGian Paolo Caviglia, Arianna Ferro, Roberta D'Ambrosio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver DiseaseSalvatore Petta, Giada Sebastiani, Mauro Viganò, et al.
Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
Pageof 30